Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Cancer Immunology, Immunotherapy : CII
|
December 12, 2013
Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma
Marijo Bilusic, Christopher R Heery, Philip M Arlen, et al.
Frontiers in Endocrinology
|
August 28, 2020
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer
Jaydira Del Rivero, Renee N Donahue, Jennifer L Marté, et al.
Journal of Oncology Practice
|
June 23, 2016
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer
Caitlin R Meeker, Daniel M Geynisman, Brian L Egleston, et al.
Clinical Genitourinary Cancer
|
December 20, 2016
Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review
Kyungsuk Jung, Pooja Ghatalia, Samuel Litwin, et al.
The Prostate
|
February 23, 2026
Metabolomic Insights Into Saliva as a Non-Invasive Surrogate for Serum to Enable Community-Based Biomarker Investigation
Alireza Abdshah, Mohammad Alyamani, Robert A Burgess, et al.
Journal for Immunotherapy of Cancer
|
September 7, 2019
Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
Marijo Bilusic, Christopher R Heery, Julie M Collins, et al.
Prostate Cancer and Prostatic Diseases
|
January 26, 2022
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)
Marijo Bilusic, Nicole J Toney, Renee N Donahue, et al.
The Oncologist
|
February 17, 2021
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma
Peter Joseph DeMaria, Marijo Bilusic, Deric M Park, et al.
The Oncologist
|
May 31, 2022
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide
Keith T Schmidt, Fatima Karzai, Marijo Bilusic, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2021
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
Marijo Bilusic, Sheri McMahon, Ravi A Madan, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Cancer Immunology, Immunotherapy : CII
|
December 12, 2013
Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma
Marijo Bilusic, Christopher R Heery, Philip M Arlen, et al.
Frontiers in Endocrinology
|
August 28, 2020
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer
Jaydira Del Rivero, Renee N Donahue, Jennifer L Marté, et al.
Journal of Oncology Practice
|
June 23, 2016
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer
Caitlin R Meeker, Daniel M Geynisman, Brian L Egleston, et al.
Clinical Genitourinary Cancer
|
December 20, 2016
Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review
Kyungsuk Jung, Pooja Ghatalia, Samuel Litwin, et al.
The Prostate
|
February 23, 2026
Metabolomic Insights Into Saliva as a Non-Invasive Surrogate for Serum to Enable Community-Based Biomarker Investigation
Alireza Abdshah, Mohammad Alyamani, Robert A Burgess, et al.
Journal for Immunotherapy of Cancer
|
September 7, 2019
Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
Marijo Bilusic, Christopher R Heery, Julie M Collins, et al.
Prostate Cancer and Prostatic Diseases
|
January 26, 2022
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)
Marijo Bilusic, Nicole J Toney, Renee N Donahue, et al.
The Oncologist
|
February 17, 2021
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma
Peter Joseph DeMaria, Marijo Bilusic, Deric M Park, et al.
The Oncologist
|
May 31, 2022
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide
Keith T Schmidt, Fatima Karzai, Marijo Bilusic, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2021
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
Marijo Bilusic, Sheri McMahon, Ravi A Madan, et al.
Page
of 8